Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Archer

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Menopause (New York, N.Y.)|April 14, 2010
A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifenDavid F Archer
The Journal of Reproductive Medicine|May 5, 2007
Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current dataDavid F Archer
Menopause (New York, N.Y.)|July 16, 2009
Efficacy and tolerability of local estrogen therapy for urogenital atrophyDavid F Archer
The Journal of Steroid Biochemistry and Molecular Biology|September 10, 2014
Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophyDavid F Archer
Pharmacoepidemiology and Drug Safety|December 21, 2006
Medical decisions regarding hormone therapy for menopausal women are significantly influenced by the mediaDavid F Archer
Menopause (New York, N.Y.)|June 25, 2020
Ospemifene: less venous thrombosis than other selective estrogen receptor modulators in postmenopausal women with vulvo vaginal atrophyDavid F Archer
Endocrine|November 16, 2004
Neoplasia of the female reproductive tract: effects of hormone therapyDavid F Archer
Menopause (New York, N.Y.)|November 25, 2003
Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal womenDavid F Archer,
Southern Medical Journal|April 15, 2015
Authors' responseDavid F Archer
Southern Medical Journal|November 4, 2014
Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits"David F Archer
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Menopause (New York, N.Y.)|April 14, 2010
A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifenDavid F Archer
The Journal of Reproductive Medicine|May 5, 2007
Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current dataDavid F Archer
Menopause (New York, N.Y.)|July 16, 2009
Efficacy and tolerability of local estrogen therapy for urogenital atrophyDavid F Archer
The Journal of Steroid Biochemistry and Molecular Biology|September 10, 2014
Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophyDavid F Archer
Pharmacoepidemiology and Drug Safety|December 21, 2006
Medical decisions regarding hormone therapy for menopausal women are significantly influenced by the mediaDavid F Archer
Menopause (New York, N.Y.)|June 25, 2020
Ospemifene: less venous thrombosis than other selective estrogen receptor modulators in postmenopausal women with vulvo vaginal atrophyDavid F Archer
Endocrine|November 16, 2004
Neoplasia of the female reproductive tract: effects of hormone therapyDavid F Archer
Menopause (New York, N.Y.)|November 25, 2003
Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal womenDavid F Archer,
Southern Medical Journal|April 15, 2015
Authors' responseDavid F Archer
Southern Medical Journal|November 4, 2014
Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits"David F Archer
Pageof 20